logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Calcitonin class drugs

    FiltersReset Filters
    3 results

    • calcitonin salmon

      (Calcitonin Salmon)
      ENDO USA, Inc.
      Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget's disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients who cannot use alternative therapies. Its efficacy in fracture reduction for osteoporosis is not established, and ongoing therapy should be periodically re-evaluated due to potential malignancy risks.

    • calcitonin salmon

      (CALCITONIN SALMON)
      Cipla USA Inc.
      Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in women more than five years postmenopause. It is intended for patients who do not respond to, or cannot use, alternative treatments. Regular re-evaluation is recommended due to potential malignancy risks.

    • miacalcin

      (calcitonin salmon)
      Mylan Institutional LLC
      Usage: Miacalcin injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients unsuitable for alternative therapies. Its use should be periodically re-evaluated due to potential malignancy associations. No fracture reduction efficacy has been demonstrated for osteoporosis treatment.